Home » Authors » Trista Morrison

Articles by Trista Morrison

Big Pharma Moves Out of CVD, Big Biotech Moves In

Aug. 31, 2009

By Trista Morrison

NewCo News: With Funding in Hand, Aragon on a Seek and Destroy Mission

Aug. 27, 2009

By Trista Morrison

Despite Hubbub, BMS/Medarex Deal Expected to Go Through

Aug. 26, 2009

By Trista Morrison

Shopping for Troubled Biotechs, Ligand Buys Neurogen for $11M

Aug. 25, 2009

By Trista Morrison

VC Model Not Broken, but Needs 'Tailor-Made' Tune Up

Aug. 24, 2009

By Trista Morrison

Innovation Gap Got You Down? Domain has $500M for NewCos

Aug. 24, 2009

By Trista Morrison

NewCo News: Colby's Pipeline of Inhibitors Targeting Hypoxia in Cancer

Aug. 20, 2009

By Trista Morrison

D-Pharm IPO/Rights Deal Nabs $23M for Phase III Stroke Trial

Aug. 19, 2009

By Trista Morrison

D-Pharm IPO/Rights Deal Nabs $23M for Phase III Stroke Trial

Aug. 18, 2009

By Trista Morrison

'Best' Candidates May Not Fit Through IPO Window's Crack

Aug. 17, 2009

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...